Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DHAINASDAQ:HSDTNASDAQ:LYRANASDAQ:TNON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDHAIDIH Holding US$0.22-8.0%$0.21$0.12▼$3.67$11.36M0.03831,302 shs3.41 million shsHSDTHelius Medical Technologies$0.33+1.9%$3.16$0.30▼$24.00$170K1.121.53 million shs3.78 million shsLYRALyra Therapeutics$12.86+11.9%$8.64$3.81▼$37.50$15.23M-0.01187,750 shs127,574 shsTNONTenon Medical$0.90+1.2%$1.07$0.85▼$15.79$6.74M1.232.50 million shs69,141 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDHAIDIH Holding US-8.04%-0.14%-5.52%-15.15%-93.02%HSDTHelius Medical Technologies+1.88%+5.30%-92.20%-94.57%-98.16%LYRALyra Therapeutics+11.92%+25.10%+180.17%+64.98%-2.09%TNONTenon Medical+1.17%+3.55%-19.08%-62.88%+60.25%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDHAIDIH Holding US0.2718 of 5 stars0.03.00.00.00.61.70.0HSDTHelius Medical Technologies0.2669 of 5 stars0.02.00.00.01.10.80.6LYRALyra Therapeutics2.349 of 5 stars3.24.00.00.01.11.70.6TNONTenon Medical2.2608 of 5 stars3.55.00.00.00.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDHAIDIH Holding US 0.00N/AN/AN/AHSDTHelius Medical Technologies 2.00HoldN/AN/ALYRALyra Therapeutics 2.33Hold$100.00677.60% UpsideTNONTenon Medical 3.00Buy$4.67419.56% UpsideCurrent Analyst Ratings BreakdownLatest HSDT, DHAI, TNON, and LYRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2025TNONTenon MedicalCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/9/2025TNONTenon MedicalAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.00(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDHAIDIH Holding US$64.47M0.16N/AN/A($0.80) per share-0.28HSDTHelius Medical Technologies$520K0.33N/AN/A$4.26 per share0.08LYRALyra Therapeutics$1.53M11.18N/AN/A$8.86 per share1.45TNONTenon Medical$3.28M2.08N/AN/A$0.71 per share1.27Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDHAIDIH Holding US-$8.44M-$0.30N/A∞N/A-13.59%N/A-25.97%N/AHSDTHelius Medical Technologies-$11.74M-$47.53N/A∞N/A-3,010.14%-418.82%-243.54%8/11/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)TNONTenon Medical-$13.67M-$27.23N/A∞N/A-417.57%-558.92%-129.73%8/11/2025 (Estimated)Latest HSDT, DHAI, TNON, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025TNONTenon Medical-$1.06-$1.01+$0.05-$1.01$0.76 million$0.73 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million5/1/2025Q1 2025HSDTHelius Medical Technologies-$0.58-$0.51+$0.07-$0.51N/A$0.05 million3/25/2025Q4 2024HSDTHelius Medical Technologies-$14.10-$15.45-$1.35-$1.03$0.10 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDHAIDIH Holding USN/AN/AN/AN/AN/AHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDHAIDIH Holding USN/A0.510.34HSDTHelius Medical TechnologiesN/A1.691.13LYRALyra TherapeuticsN/A2.962.96TNONTenon MedicalN/A5.465.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDHAIDIH Holding US27.76%HSDTHelius Medical Technologies18.63%LYRALyra Therapeutics95.62%TNONTenon Medical22.74%Insider OwnershipCompanyInsider OwnershipDHAIDIH Holding US49.58%HSDTHelius Medical Technologies17.90%LYRALyra Therapeutics3.25%TNONTenon Medical0.33%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDHAIDIH Holding USN/A47.34 million23.87 millionN/AHSDTHelius Medical Technologies30530,000433,000Not OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableTNONTenon Medical87.59 million7.57 millionNot OptionableHSDT, DHAI, TNON, and LYRA HeadlinesRecent News About These CompaniesTenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar FusionJune 12, 2025 | accessnewswire.comTenon Medical, Inc.: Tenon Medical Reports First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deTenon Medical, Inc.: Tenon Medical Reports First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deTenon Medical, Inc. (TNON) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comTenon Medical Reports First Quarter 2025 Financial ResultsMay 13, 2025 | accessnewswire.comTenon Medical, Inc. Announces Timing of First Quarter 2025 Financial ResultsApril 29, 2025 | accessnewswire.comAlliance Global Partners Initiates Coverage of Tenon Medical (TNON) with Buy RecommendationApril 10, 2025 | msn.comTenon Medical initiated with a Buy at Alliance Global PartnersApril 9, 2025 | markets.businessinsider.comTenon Medical files to sell 5.67M shares of common stock for holdersApril 5, 2025 | markets.businessinsider.comTenon gets FDA clearance for Catamaran SI Joint Fusion System indicationMarch 26, 2025 | markets.businessinsider.comTenon Medical prices $2.5M registered direct offering at $2.00March 26, 2025 | markets.businessinsider.comFDA clears Tenon Medical’s Catamaran system expansionMarch 26, 2025 | investing.comTenon Medical dips 6%, prices $2.5M direct offeringMarch 26, 2025 | msn.comTenon Medical earns expanded indication for SI joint fusion systemMarch 25, 2025 | beckersspine.comTenon Medical Shares Jump After FDA Clears Joint Drug for Broader UseMarch 25, 2025 | marketwatch.comTenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesMarch 25, 2025 | accessnewswire.comTenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesMarch 25, 2025 | accessnewswire.comTenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal FusionMarch 24, 2025 | accessnewswire.comTenon Medical, Inc. (NASDAQ:TNON) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | msn.comEarnings call transcript: Tenon Medical’s Q4 2024 results show revenue growthMarch 22, 2025 | uk.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHSDT, DHAI, TNON, and LYRA Company DescriptionsDIH Holding US NASDAQ:DHAI$0.22 -0.02 (-8.04%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$0.22 0.00 (-0.32%) As of 04:33 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Helius Medical Technologies NASDAQ:HSDT$0.33 +0.01 (+1.88%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$0.32 -0.01 (-1.84%) As of 04:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Lyra Therapeutics NASDAQ:LYRA$12.86 +1.37 (+11.92%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$12.60 -0.25 (-1.98%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Tenon Medical NASDAQ:TNON$0.90 +0.01 (+1.17%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$0.90 0.00 (-0.24%) As of 06/24/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
